Resistance Testing Case Study

1
Resistance TestingCase Study

• Donna Sweet, M.D.

2
Disclosure of Financial RelationshipsThis
speaker has the following significant financial
relationships with commercial entities to
disclose

• Speakers Bureau for BMS, Abbott, Gilead, Pfizer,
  Merck, GSK, Orthobiotech, and Roche

This slide set has been peer-reviewed to ensure
that there are no conflicts of interest
represented in the presentation.
3
Medication Tracking Chart
4
HIV/AIDS Flowsheet10/4/2000 12/17/2001
5
HIV/AIDS Flowsheet2/13/2002 1/15/2003
6
HIV/AIDS Flowsheet4/14/2003 3/4/2004
7
HIV/AIDS Flowsheet4/29/2004 3/15/2005
8
HIV/AIDS Flowsheet6/22/2005 12/11/2006
9
Genotype Report
10
GenotypR
11
Virtual Phenotype ReportMarch 19, 2002
12
Virtual Phenotype ReportClose-UpMarch 19, 2002
13
Virtual PhenotypeReportJanuary 28, 2003
14
Virtual Phenotype ReportClose-UpJanuary 28, 2003
15
Virtual PhenotypeReportJuly 3, 2003
16
Virtual Phenotype ReportClose-UpJuly 3, 2003
17
Virtual PhenotypeReportFeb 5, 2004
18
Virtual Phenotype ReportClose-Up Feb 5, 2004
19
Genotype ReportAugust 29, 2006